Suppressor of cytokine signaling (SOCS)1 is a key determinant of differential macrophage activation and function

Journal of Leukocyte Biology

Volumn 90, Issue 5, 2011, Pages 845-854

  Whyte, Claire S ^a   Bishop, Eileen T ^a   Rückerl, Dominik ^b   Gaspar Pereira, Silvia ^a   Barker, Robert N ^a   Allen, Judith E ^b   Rees, Andrew J ^c   Wilson, Heather M ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Arginase I; Brugia malayi; Inducible nitric oxide synthase; Inflammation; M1 activation; M2 activation

Indexed keywords

ARGINASE; ARGINASE 1; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; SMALL INTERFERING RNA; SUPPRESSOR OF CYTOKINE SIGNALING 1;

ARTICLE; BRUGIA MALAYI; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; FEMALE; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MACROPHAGE ACTIVATION; MACROPHAGE FUNCTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; T LYMPHOCYTE; UPREGULATION;

ANIMALS; ARGINASE; BRUGIA MALAYI; FILARIASIS; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-4; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED BALB C; NITRIC OXIDE SYNTHASE TYPE II; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; UP-REGULATION; WOUND HEALING;

BRUGIA MALAYI; MUS;

EID: 80055096913     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1110644     Document Type: Article

References (50)

1. Mantovani, A., Sica, A., Locati, M. (2005) Macrophage polarization comes of age. Immunity 23, 344-346.
2. Martinez, F. O., Sica, A., Mantovani, A., Locati, M. (2008) Macrophage activation and polarization. Front. Biosci. 13, 453-461.
3. Wilson, H. M. (2010) Macrophages heterogeneity in atherosclerosis-implications for therapy. J. Cell. Mol. Med. 14, 2055-2065.
4. Vernon, M. A., Mylonas, K. J., Hughes, J. (2010) Macrophages and renal fibrosis. Semin. Nephrol. 30, 302-317.
5. Gordon, S., Martinez, F. O. (2010) Alternative activation of macrophages: mechanism and function. Immunity 32, 593-604.
6. Mosser, D. M., Edwards, J. P. (2008) Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8, 958-969.
7. Stout, R. D., Watkins, S. K., Suttles, J. (2009) Functional plasticity of macrophages: in situ reprogramming of tumor-associated macrophages. J. Leukoc. Biol. 86, 1105-1109.
8. Mylonas, K. J., Nair, M. G., Prieto-Lafuente, L., Paape, D., Allen, J. E. (2009) Alternatively activated macrophages elicited by helminth infection can be reprogrammed to enable microbial killing. J. Immunol. 182, 3084-3094.
9. Erwig, L. P., Stewart, K. N., Rees, A. J. (2000) Macrophages from inflamed but not normal glomeruli are unresponsive to anti-inflammatory cytokines. Am. J. Pathol. 156, 295-301.
10. Wynn, T. A. (2004) Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat. Rev. Immunol. 4, 583-594.
11. Yoshimura, A., Naka, T., Kubo, M. (2007) SOCS proteins, cytokine signaling and immune regulation. Nat. Rev. Immunol. 7, 454-465.
12. Dalpke, A., Heeg, K., Bartz, H., Baetz, A. (2008) Regulation of innate immunity by suppressor of cytokine signaling (SOCS) proteins. Immunobiology 213, 225-235.
13. Tang, J., Kozaki, K., Farr, A. G., Martin, P. J., Lindahl, P., Betsholtz, C., Raines, E. W. (2005) The absence of platelet-derived growth factor-B in circulating cells promotes immune and inflammatory responses in atherosclerosis-prone ApoE-/-mice. Am. J. Pathol. 167, 901-912.
14. Wong, P. K., Egan, B., Croker, A., O'Donnell, K., Sims, P. J., Drake, S., Kiu, H., McManus, E. J., Alexander, W. S., Roberts, A. W., Wicks, I. P. (2006) SOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritis. J. Clin. Invest. 116, 1571-1581.
15. Liu, Y., Stewart, K. N., Bishop, E. T., Marek, C. M., Kluth, D. C., Rees, A. J., Wilson, H. M. (2008) Unique expression of suppressor of cytokine signaling 3 is essential for classical macrophage activation in rodents in vitro and in vivo. J. Immunol. 180, 6270-6278.
16. Marine, J. C., Topham, D. J., McKay, C., Wang, D., Parganas, E., Stravopodis, D., Yoshimura, A., Ihle, J. N. (1999) SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality. Cell 98, 609-616.
17. Starr, R., Metcalf, D., Elefanty, A. G., Brysha, M., Willson, T. A., Nicola, N. A., Hilton, D. J., Alexander, W. S. (1998) Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. Proc. Natl. Acad. Sci. USA 95, 14395-14399.
18. Brysha, M., Zhang, J-G., Bertolino, P., Corbin, J. E., Alexander, W. S., Nicola, N. A., Hilton, D. J., Starr, R. (2001) Suppressor of cytokine signaling-1 attenuates the duration of interferon-γ signal transduction in vitro and in vivo. J. Biol. Chem. 276, 22-086-22-089.
19. Yasukawa, H., Ohishi, M., Mori, H., Murakami, M., Chinen, T., Aki, D., Hanada, T., Takeda, K., Akira, S., Hoshijima, M., Hirano, T., Chien, K. R., Yoshimura, A. (2003) IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages. Nat. Immunol. 4, 551-556.
20. Croker, B. A., Krebs, D. L., Zhang, J. G., Wormald, S., Willson, T. A., Stanley, E. G., Robb, L., Greenhalgh, C. J., Forster, I., Clausen, V., Nicola, N. A., Metcalf, D., Hilton, D. J., Roberts, A. W., Alexander, W. S. (2003) SOCS3 negatively regulates IL-6 signaling in vivo. Nat. Immunol. 4, 540-545.
21. Lang, R., Pauleau, A. L., Parganas, E., Takahashi, Y., Mages, J., Ihle, J. N., Rutschman, R., Murray, P. J. (2003) SOCS3 regulates the plasticity of gp130 signaling. Nat. Immunol. 4, 546-550.
22. O'Connor, J. C., Sherry, C. L., Guest, C. B., Freund, G. G. (2007) Type 2 diabetes impairs insulin receptor substrate-2-mediated phosphatidylinositol 3-kinase activity in primary macrophages to induce a state of cytokine resistance to IL-4 in association with overexpression of suppressor of cytokine signaling-3. J. Immunol. 178, 6886-6893.
23. Zhou, H., Miki, R., Eeva, M., Fike, M., Seligson, D., Yang, L., Yoshimura, A., Teitell, M. A., Jamieson, C. A., Cacalano, N. A. (2007) Reciprocal regulation of SOCS 1 and SOCS3 enhances resistance to ionizing radiation in glioblastoma multiforme. Clin. Cancer Res. 13, 2344-2353.
24. Hanada, T., Tanaka, K., Matsumura, Y., Yamauchi, M., Nishinakamura, H., Aburatani, H., Mashima, R., Kubo, M., Kobayashi, T., Yoshimura, A. (2005) Induction of hyper Th1 cell-type immune responses by dendritic cells lacking the suppressor of cytokine signaling-1 gene. J. Immunol. 174, 4325-4332.
25. Baetz, A., Frey, M., Heeg, K., Dalpke, A. H. (2004) Suppressor of cytokine signaling (SOCS) proteins indirectly regulate Toll-like receptor signaling in innate immune cells. J. Biol. Chem. 279, 54708-54715.
26. Mohrs, M., Holscher, C., Brombacher, F. (2000) Interleukin-4 receptor α-deficient BALB/c mice show an unimpaired T helper 2 polarization in response to Leishmania major infection. Infect. Immun. 68, 1773-1780.
27. Loke, P., MacDonald, A. S., Robb, A., Maizels, R. M., Allen, J. E. (2000) Alternatively activated macrophages induced by nematode infection inhibit proliferation via cell-to-cell contact. Eur. J. Immunol. 30, 2669-2678.
28. Wilson, H. M., Stewart, K. N., Brown, P. A. J., Anegon, I., Chettibi, S., Rees, A. J., Kluth, D. C. (2002) Bone marrow derived macrophages genetically modified to produce IL-10 reduce injury in experimental glomerulonephritis. Mol. Ther. 6, 710-717.
29. Nair, M. G., Gallagher, I. J., Taylor, M. D., Loke, P., Coulson, P. S., Wilson, R. A., Maizels, R. M., Allen, J. E. (2005) Chitinase and Fizz family members are a generalized feature of nematode infection with selective upregulation of Yml and Fizzl by antigen-presenting cells. Infect. Immun. 73, 385-394.
30. Yu, C. R., Mahdi, R. M., Ebong, S., Vistica, B. P., Chen, J., Guo, Y., Gery, I., Egwuagu, C. E. (2004) Cell proliferation and STAT6 pathway are negatively regulated in T cells by STAT1 and suppressors of cytokine signaling. J. Immunol. 173, 737-746.
31. Corraliza, I. M., Campo, M. L., Soler, G., Modolell, M. (1994) Determination of arginase activity in macrophages: a micromethod. J. Immunol. Methods 174, 231-235.
32. Dimitriou, I. D., Clemenza, L., Scotter, A. J., Chen, G., Guerra, F. M., Rottapel, R. (2008) Putting out the fire: coordinated suppression of the innate and adaptive immune systems by SOCS1 and SOCS3 proteins. Immunol. Rev. 224, 265-283.
33. Dickensheets, H., Vazquez, N., Sheikh, F., Gingras, S., Murray, P. J., Ryan, J. J., Donnelly, R. P. (2007) Suppressor of cytokine signaling-1 is an IL-4-inducible gene in macrophages and feedback inhibits IL-4 signaling. Genes Immun. 8, 21-27.
34. Loke, P., Gallagher, I., Nair, M. G., Zang, X., Brombacher, F., Mohrs, M., Allison, J. P., Allen, J. E. (2007) Alternative activation is an innate response to injury that requires CD4+ T cells to be sustained during chronic infection. J. Immunol. 179, 3926-3936.
35. Pesce, J. T., Ramalingam, T. R., Mentink-Kane, M. M., Wilson, M. S., El Kasmi, K. C., Smith, A. M., Thompson, R. W., Cheever, A. W., Murray, P. J., Wynn, T. A. (2009) Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis. PLoS Pathog. 5, e1000371.
36. Nelms, K., Keegan, A. D., Zamorano, J., Ryan, J. J., Paul, W. E. (1999) The IL-4 receptor: signaling mechanisms and biologic functions. Annu. Rev. Immunol. 17, 701-738.
37. MacKinnon, A. C., Farnworth, S. L., Hodkinson, P. S., Henderson, N. C., Atkinson, K. M., Leffler, H., Nilsson, U. J., Haslett, C., Forbes, S. J., Sethi, T. (2008) Regulation of alternative macrophage activaton by galectin-3. J. Immunol. 180, 2650-2658.
38. Rauh, M. J., Ho, V., Pereira, C., Sham, A., Sly, L. M., Lam, V., Huxham, L., Minchinton, A. I., Mui, A., Krystal, G. (2005) SHIP represses the generaton of alternatively activated macrophages. Immunity 23, 361-374.
39. El Kasmi, K. C., Qualls, J. E., Pesce, J. T., Smith, A. M., Thompson, R. W., Henao-Tamayo, M., Basaraba, R. J., König, T., Schleicher, U., Koo, M. S., et al. (2008) Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens. Nat. Immunol. 9, 1399-1406.
40. Nakagawa, R., Naka, T., Tsutsui, H., Fujimoto, M., Kimura, A., Abe, T., Seki, E., Sato, S., Takeuchi, O., Takeda, K., Akira, S., Yamanishi, K., Kawase, I., Nakanishi, K., Kishimoto, T. (2002) SOCS-1 participates in negative regulation of LPS responses. Immunity 17, 677-687.
41. Kinjyo, I., Hanada, T., Inagaki-Ohara, K., Mori, H., Aki, D., Ohishi, M., Yoshida, H., Kubo, M., Yoshimura, A. (2002) SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity 17, 583-591.
42. Gingras, S., Parganas, E., de Pauw, A., Ihle, J. N., Murray, P. J. (2004) Re-examination of the role of suppressor of cytokine signaling 1 (SOCS1) in the regulation of Toll-like receptor signaling. J. Biol. Chem. 279, 54702-54707.
43. Prêle, C. M., Woodward, E. A., Bisley, J., Keith-Magee, A., Nicholson, S. E., Hart, P. H. (2008) SOCS1 regulates the IFN but not NFκB pathway in TLR-stimulated human monocytes and macrophages. J. Immunol. 181, 8018-8026.
44. Babu, S., Kumaraswami, V., Nutman, T. B. (2009) Alternatively activated and immunoregulatory monocytes in human filarial infections. J. Infect. Dis. 199, 1827-1837.
45. Bystrom, J., Evans, I., Newson, J., Stables, M., Toor, I., van Rooijen, N., Crawford, M., Colville-Nash, P., Farrow, S., Gilroy, D. W. (2008) Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMP. Blood 112, 4117-4127.
46. Fujimoto, M., Tsutsui, H., Yumikura-Futatsugi, S., Ueda, H., Xingshou, O., Abe, T., Kawase, I., Nakanishi, K., Kishimoto, T., Naka, T. (2002) A regulatory role for suppressor of cytokine signaling-1 in T(h) polarization in vivo. Int. Immunol. 14, 1343-1350.
47. Egwuagu, C. E., Yu, C. R., Zhang, M., Mahdi, R. M., Kim, S. J., Gery, I. (2002) Suppressors of cytokine signaling proteins are differentially expressed in Th1 and Th2 cells: implications for Th cell lineage commitment and maintenance. J. Immunol. 168, 3181-3187.
48. Hesse, M., Modolell, M., La Flamme, A. C., Schito, M., Fuentes, J. M., Cheever, A. W., Pearce, E. J., Wynn, T. A. (2001) Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism. J. Immunol. 167, 6533-6544.
49. Wilson, H. M., Chettibi, S., Jobin, C., Walbaum, D., Rees, A. J., Kluth, D. C. (2005) Inhibition of macrophage nuclear factor-κ B (NF-κB) leads to a dominant anti-inflammatory phenotype that attenuates glomerular inflammation in vivo. Am. J. Pathol. 167, 27-37.
50. Shen, L., Evel-Kabler, K., Strube, R., Chen, S. Y. (2004) Silencing of SOCS1 enhances antigen presentation by dendritic cells and antigen-specific anti-tumor immunity. Nat. Biotechnol. 22, 1546-1553.